✦ LIBER ✦

Serum determination of CA 19-9 in diagnosing pancreatic cancer: An obituary

✍ Scribed by R. Pezzilli; R. Casadei; L. Calculli; D. Santini; A.M. Morselli-Labate

Book ID: 119229525
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 66 KB
Volume: 42
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2009.04.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ca 19-9 serum course and prognosis of pa

Ca 19-9 serum course and prognosis of pancreatic cancer

✍ Safi, Farouk ;Schlosser, Wolfgang ;Falkenreck, Stephanie ;Beger, Hans G. 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 589 KB

Prognostic significance of serum CA19-9

Prognostic significance of serum CA19-9 levels in resected pancreatic cancer

✍ Fujimoto, Koji ;Koizumi, Shunzou ;Nishimura, Satoru ;Sakai, Satoaki ;Nakamura, Y 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 512 KB

Evaluation of CA 19-9 as a serum tumour

Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer

✍ Haglund, C; Roberts, P J; Kuusela, P; Scheinin, T M; Mäkelä, O; Jalanko, H 📂 Article 📅 1986 🏛 Nature Publishing Group 🌐 English ⚖ 678 KB

An initial appraisal of the value of ser

An initial appraisal of the value of serum carbohydrate antigenic determinant (CA 19-9) levels in patients with pancreatic cancer

✍ Buamah, Paul K.; Cornell, Christopher; Venables, Christopher W.; Skillen, Andrew 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 1000 KB

Serum CA 19-9 in the postsurgical follow

Serum CA 19-9 in the postsurgical follow-up of patients with pancreatic cancer

✍ Edoardo Beretta; Alberto Malesci; Alessandro Zerbi; Alberto Mariani; Michele Car 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 2 views

Serum ca 50 as a tumor marker in pancrea

Serum ca 50 as a tumor marker in pancreatic cancer: A comparison with CA 19-9

✍ Caj Haglund; Pentti Kuusela; Hannu Jalanko; Peter J. Roberts 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 459 KB

CA 50 is a new tumor marker based on a monoclonal anti-carcinoid tumor, 2 cystadenocarcinomas, 2 anaplastic carcibody (MAb) against a human colorectal carcinoma cell line.The nomas, 15 poorly differentiated and 39 well-to moderately-CA 50 antigen is similar, but not identical, to the tumor different